Literature DB >> 28733916

Hysterectomy technique and risk of pelvic organ prolapse repair: a Danish nationwide cohort study.

Rune Lykke1, Ea Løwenstein2, Jan Blaakær3, Helga Gimbel2.   

Abstract

PURPOSE: The purpose was to investigate, in a large cohort, how hysterectomy technique influences the incidence of subsequent pelvic organ prolapse (POP) repair among women hysterectomized for benign conditions.
METHODS: From the Danish National Patient Registry, we collected data on all hysterectomies on benign indications, and all POP operations performed in Denmark from January 1, 1977 to June 10, 2016. We excluded patients with prior POP repair. We analyzed the incidence of POP surgery by cumulative incidence curves and hazard ratio (HR) for women with and without POP diagnoses or concomitant POP repair at hysterectomy.
RESULTS: In all, 178,282 women underwent hysterectomy in the study period and were included in the cohort. When examining the crude HR for the risk of POP repair after hysterectomy, vaginal hysterectomy (VH) had a threefold rise in HR compared to total abdominal hysterectomy (TAH). When restricting the analyses to women without POP at time of hysterectomy, the HR for VH decreased to 1.25. The same tendency was noticed when stratifying by compartment. In the subgroup of women without POP at hysterectomy, we found that supravaginal abdominal hysterectomy had a small increase in risk compared to TAH. Laparoscopic hysterectomy had the same risk of POP as TAH.
CONCLUSIONS: Overall, we found only small differences in risk of POP repair between the different hysterectomy techniques after restricting the analyses to women without POP at hysterectomy.

Entities:  

Keywords:  Cohort study; Hysterectomy; Pelvic organ prolapse; Urogynecology

Mesh:

Year:  2017        PMID: 28733916     DOI: 10.1007/s00404-017-4470-1

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  1 in total

1.  Pelvic organ prolapse surgery following hysterectomy with benign indication: a national cohort study in Taiwan.

Authors:  Huei-Kai Huang; Dah-Ching Ding
Journal:  Int Urogynecol J       Date:  2018-06-19       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.